`
`Filed On Behalf Of:
`Novartis Pharmaceuticals Corporation
`
`By:
`Nicholas N. Kallas
`nkallas@Venable.com
`(212) 218-2243
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BIOCON PHARMA LIMITED,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`
`Case IPR2020-01263
`Patent 8,101,659
`
`
`
`PATENT OWNER’S EXHIBIT LIST 1
`
`
`
`
`
`
`
`Exhibit
`
`2001
`
`Description
`Merriam Webster’s Medical Dictionary
`(1995), cover page and pages 97, 174, 278,
`308, 684 (Entries for cardiomyopathy,
`diastole, heart failure, hypertension, and
`systole)
`
`Abbreviation
`
`Merriam-
`Webster’s
`
`2002
`
`2003
`
`Böhm et al., “DESENSITIZATION OF
`ADENYLATE CYCLASE AND
`INCREASE OF Giα IN CARDIAC
`HYPERTROPHY DUE TO ACQUIRED
`HYPERTENSION,” Hypertension, Vol.
`20, No. 1, July 1992, 103–12
`
`Smits et al., “EFFECT OF
`ENDOPEPTIDASE 24.11 INHIBITION
`IN CONSCIOUS CARDIOMYOPATHIC
`HAMSTERS,” Journal of Pharmacology
`and Experimental Therapeutics, Vol. 254,
`No. 1, April 2, 1990, 176–79
`
`Böhm
`
`Smits
`
`2004
`
`Expert Declaration of Dr. Reza Tabrizchi
`
`Tabrizchi Decl.
`
`2005
`
`Curriculum Vitae of Dr. Reza Tabrizchi
`
`Tabrizchi C.V.
`
`
`
`
`
`
`
`
`
`
`
`
`1
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
` I certify that a copy of Patent Owner’s Exhibit List 1 was served on November
`
`20, 2020 by causing it to be sent by email to counsel for Petitioner at the following
`
`email addresses:
`
`Christopher Ferenc (christopher.ferenc@katten.com)
`
`Brian Sodikoff (brian.sodikoff@katten.com)
`
`
`Dated: November 20, 2020
`
`
`
`/Nicholas N. Kallas/
`Nicholas N. Kallas (Reg. No. 31,530)
`
`
`
`2
`
`
`
`